Safety and Efficacy of Belatacept in Pancreas Transplantation: A Case Series
- 10 March 2025
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 39 (3) , e70131
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Belatacept in Pancreas Transplantation: Promising Insights From a Cohort SeriesTransplant International, 2024
- Belatacept Rescue Therapy in the Early Period After Simultaneous Kidney-Pancreas TransplantationTransplant International, 2024
- Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trialAmerican Journal of Transplantation, 2020
- Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic ParametersTransplantation Direct, 2019
- Conversion From Tacrolimus to Belatacept to Prevent the Progression of Chronic Kidney Disease in Pancreas Transplantation: Case Report of Two PatientsAmerican Journal of Transplantation, 2014